ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
CeCors Inc (PK)

CeCors Inc (PK) (CEOS)

0,0074
0,00
(0,00%)
Fermé 06 Juin 10:00PM

CeCors Inc (PK) (CEOS) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,0074
( - )
Prix Achat
0,0042
Prix Vente
0,008
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,0006 Plage de 52 semaines 0,0125
Cap du marché
Clôture Veille
0,0074
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 179 018
Actions en circulation
313 079 838
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-0,02
Bénéfice par action (BPA)
-0,41
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-5,01M

À propos de CeCors Inc (PK)

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery o... Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. The company was incorporated in 2002 and is based in Toronto, Canada. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Toronto, Canada
Fondé
2026
CeCors Inc (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker CEOS. Le dernier cours de clôture d'CeCors (PK) était de US$0,01. Au cours de la dernière année, les actions de CeCors (PK) ont été négociées dans une fourchette de prix de US$ 0,0006 à US$ 0,0125.

CeCors (PK) compte actuellement 313 079 838 actions en circulation. La capitalisation boursière d'CeCors (PK) est de US$2,32 million. CeCors (PK) a un ratio cours/bénéfice (ratio PE) de -0.02.

CEOS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.001117.46031746030.00630.00740.0040382228010.0069713CS
40.0004857.013738250180.0069150.0075430.0040381266680.00690873CS
120.0044146.6666666670.0030.00890.00251848960.00694853CS
260.0048184.6153846150.00260.00890.00121658470.00503031CS
52-0.0011-12.94117647060.00850.01250.00061761940.00546419CS
156-0.0296-800.0370.05470.00064896840.02284423CS
260-0.1226-94.30769230770.130.1640.00065710660.03735242CS

CEOS - Frequently Asked Questions (FAQ)

What is the current CeCors Inc (PK) share price?
The current share price of CeCors Inc (PK) is US$ 0,0074
How many CeCors Inc (PK) shares are in issue?
CeCors Inc (PK) has 313 079 838 shares in issue
What is the market cap of CeCors Inc (PK)?
The market capitalisation of CeCors Inc (PK) is USD 2,32M
What is the 1 year trading range for CeCors Inc (PK) share price?
CeCors Inc (PK) has traded in the range of US$ 0,0006 to US$ 0,0125 during the past year
What is the PE ratio of CeCors Inc (PK)?
The price to earnings ratio of CeCors Inc (PK) is -0,02
What is the registered address of CeCors Inc (PK)?
The registered address for CeCors Inc (PK) is 17 Belfield Road, Toronto, Ontario, M9W1E8
What is the CeCors Inc (PK) website address?
The website address for CeCors Inc (PK) is www.psykeyworld.com
Which industry sector does CeCors Inc (PK) operate in?
CeCors Inc (PK) operates in the Biotechnology & Life Sciences sector

CEOS Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion